In another study of stage II-IV high-grade epithelial ovarian cancer, deleterious germline BRCA mutations were detected and patients’ mean age at diagnosis was younger for patients harboring BRCA1 mutations than patients harboring BRCA2 mutations (52 years vs. 57 years, respectively, P = 0.06)31. Here, BRCA2 is linked to ovarian carcinoma.